我国社会药房自有品牌的发展现状分析

金瑜,李歆,周志良,邵蓉*

中国药学杂志 ›› 2014, Vol. 49 ›› Issue (18) : 1665-1669.

PDF(987 KB)
PDF(987 KB)
中国药学杂志 ›› 2014, Vol. 49 ›› Issue (18) : 1665-1669. DOI: 10.11669/cpj.2014.18.021
药事管理

我国社会药房自有品牌的发展现状分析

  • 金瑜1,李歆2,周志良1,邵蓉1*
作者信息 +

Analysis of Development Status of Private Label Drugs in Community Pharmacy in China

  • JIN Yu1, LI Xin2, ZHOU Zhi-liang1, SHAO Rong1*
Author information +
文章历史 +

摘要

目的 分析我国社会药房自有品牌的发展现状及以后的发展趋势。方法 首先对国外社会药房自有品牌发展进行介绍,然后对我国社会药房自由品牌的发展现状进行深入分析和未来发展展望。结果与结论 由于我国目前的药品注册审批制度和医药零售行业的发展现状等因素的制约,我国社会药房自有品牌的发展处于初步的探索阶段,目前只有贴牌加工这一种方式,但是待条件成熟社会药房自有品牌药品将具有广阔的发展前景。

Abstract

OBJECTIVE To find out China's current status of private label drugs in community pharmacy and predict their future developments.METHODS Firstly, A introduction of the development of foreign private label drugs in community pharmacy were given birth by us. Then a thorough analysis of the current status of China's private label drugs and work out the predictions of their future development were carried by us.RESULTS AND CONCLUSION Due to China's registration and approval system of drugs and current status of pharmaceutical retail industry, the private label drugs of community pharmacy can be only conducted by OEM. And they are in the exploratory phase, which private label drugs can only be manufactured by OEM. But the private label drugs have great prospects for development when the conditions are mature.

关键词

社会药房 / 自有品牌 / 自有品牌药品

Key words

community pharmacy / private brand / private label drug

引用本文

导出引用
金瑜,李歆,周志良,邵蓉*. 我国社会药房自有品牌的发展现状分析[J]. 中国药学杂志, 2014, 49(18): 1665-1669 https://doi.org/10.11669/cpj.2014.18.021
JIN Yu, LI Xin, ZHOU Zhi-liang, SHAO Rong*. Analysis of Development Status of Private Label Drugs in Community Pharmacy in China[J]. Chinese Pharmaceutical Journal, 2014, 49(18): 1665-1669 https://doi.org/10.11669/cpj.2014.18.021
中图分类号: R952   

参考文献

[1] Private Label Manufacturers Association(PLMA)[EB/OL]. 2011,http://plma.com.[2] ZHAO F. The Construction and Development of the Self-Brand of Chain Pharmacy Stores in Chain[D]. Wuhan: Wuhan University of Technology, 2007.[3] WANG C,WANG Z Y. The Development Status of US Retail Pharmacy Chains[J]. Int Bus Technol(国际商业技术), 2007,1: 66-69.[4] MA X X. Study on the private brand strategy of Chinese retail enterprise--The analysis of Watsons [D]. Beijing: University of international Business and Economics, 2006.[5] 2012-2016 China pharmaceutical industry investment analysis and Forecast Report[R]. Global Analysis Network, 2012.1.[6] HU F. How to ease the pharmaceutical industry overcapacity [N]. China Pharm News(中国医药报), 2008-06-12 (B01).[7] ZENG Y, LI Y, ZHANG X Y.Hospital pharmacists involving in community pharmacy services[J].Pharmacy Today(今日药学),2009,19(1):52-55.[8] ZHAO F, LIU X P.Strategy analysis on Chinese drug retailers implemented its private brand[J]. Chin Med Rep(中国医药导报),2009, 4(25):155-158.
PDF(987 KB)

48

Accesses

0

Citation

Detail

段落导航
相关文章

/